CHELMSFORD, Mass. — ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that it is the first company to achieve premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) to continue to market and distribute its full line of defibrillators in the U.S. The list of defibrillators that received PMA approval include the R Series® ...
from EMS via xlomafota13 on Inoreader http://ift.tt/2EAo4Cd
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose The Acute Care Surgical Unit at Groote Schuur Hospital was established in 2010 and is the first of its kind in Africa. Th...
-
Reuters Health News from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2wmMf6v
-
We assessed the association of intravenous insulin and glucose infusion with intensive care unit (ICU) and hospital mortality. from Emerge...
-
Abstract Objective This study was undertaken to examine the factors contributing to laparoscopic adjustable gastric band (LAGB) removals...
-
Abstract Background The treatment of the reverse oblique osteoporotic femur fractures is still problematic and can be complicated especial...
-
Abstract Background The treatment of the reverse oblique osteoporotic femur fractures is still problematic and can be complicated especi...
-
Objectives: After traumatic brain injury, continuous electroencephalography is widely used to detect electrographic seizures. With the devel...
-
Publication date: January 2017 Source: The Journal of Emergency Medicine, Volume 52, Issue 1 Author(s): Katherine C. Wurlitzer from ...
-
We aimed (1) to describe the characteristics of patient–ventilator asynchrony in a population of critically ill children, (2) to describe th...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου